Biomedical Science-Clinical Biochemistry
Biomedical Science-Clinical Biochemistry
BIOCHEMISTRY
Introduction
• Area of pathology concerned with analysis of bodily fluids.
• Blood, Urine
• Analysis of the soluble noncellular components of bodily fluid.
wind
• Vary from small inorganic compounds such as salts and ions to larger
organic compounds such as lipids and steroids and even drugs to
macromolecules such as albumin, enzymes and protein hormones
.
• Samples are collected in tubes appropriate to the test required.
Analytical methods
• The biochemical tests used in a clinical chemistry laboratory are designed to
accurately quantify these specific components.
• In order to reduce variation in laboratory measurement to an absolute
minimum, standard operating procedures (SOPs) and rigid quality control
testing regimes are enforced in all tests conducted.
Tend to find
liquid chromatography
-
high perform ee
(liquid chromatography
-
he -
Ms -
Mass spectrum )
Sample collection
• The principal biological fluid examined in clinical chemistry is blood serum as
distinct from blood plasma which still contains clotting factors including
fibrinogen.
• Urine is also collected for analysis and is usually a 24 h collection in a plastic
container supplied from clinical chemistry and containing an antibacterial
agent. Early morning urine (EMU) is often collected as it is considered to be
more concentrated whilst midstream urine (MSU) is often collected for
microbiological purposes.
Diabetes → - glucose in urine
\
glucose tolerant fblood
Blood
• In general blood, if not sampled by medical staff on the ward or the accident
and emergency department, will be sampled at a clinical/haematology blood
clinic collected by a qualified phlebotomist and many bio- medical scientists
are also phlebotomy trained.
• Samples are collected in tubes appropriate to the test required. For most
analytes to be measured by immu- noassay serum is the optimal fluid and
the blood is simply allowed to clot in a plain tube thereby allowing the
cellular components fibrinogen and clotting factors
Thrombin :
coagulant
↳ blotting → stroke
→ HER
coin
Ø Hemolysin is the phenomenon when red
blood cells are destructed, hemoglobin and other
intracellular components are released into the
plasma. The delivery of hemoglobin causes the
serum or plasma to appear from pale red to
cherry red color.
Ø Reason: due to a mistake in the technique of
taking venous blood.
Ø Consequences: increases Potassium,
Phosphate, ... leading to incorrect results.
Hemolysic blood tube
Principle:
Centrifugal force is generated when a mixture
is rotated in a centrifuge at a high speed.
When centrifuging a mixture of many
substances in solution, centrifugal force will
separate substances into different types to
create a separate layer.
At the end of the process, the original mixture
will be devided into separate components.
Function: Separate different substances in a
mixture into distinct layers for examination.
Centrifuge Rotofix 32A
Principle:
The blood sample is drawn for analysing, then pumped to a
system of 3 electrodes: K+, Na+, Cl- (or Li+).
The Na+ electrode is a glass tube, which is made of a material
with a very high sensitivity to Na+ ions. K+ electrode is a plastic
tube, this tube contains Valinomycin which selectes all K+ ions
in the solution flowing through it. Similarly, the Cl- (or Li+)
electrode also contains substances which is sensitive to Cl- (or
Li+) ions. The potential of each electrode is compared with a
standard and stable potential produced by the Ag/AgCl
reference electrode. The relationship of potential difference is
determined based on the Nernst equation.
pancreas
Bord ones →
cholesterol
Clinical assessments
The molecular structural categorization of bodily fluid components may
influence the biochemical tests used in their detection and quantification
Clinical chemistry is subdivided more along clinical/biological functions
relevant to the practice of medicine:
• Urea and electrolytes
• Gastro-intestinal markers
• Renal function markers
• Bone assessment
• Heart disease and lipid disorders
• Liver function markers
• Endocrine assessment
• Reproductive endocrinology
• Therapeutic drug monitoring and cancer biomarkers.
Urea and
electrolytes (U and
Es)
• Increased serum potassium level is observed in metabolic renal
tubular acidosis, shock or circulatory failure.
• Low serum potassium values are observed due to low intake of
dietary potassium over a period of time or increased loss through
kidney, vomiting or diarrhea
• Increased secretion of adrenal steroids or some diuretics may also
promote the loss of potassium
→
eortieoidhloitieumgdmfftlt.la:7 man
Metabolism and gastrointestinal markers
Creatinine → detect kidney 's problem
network of small
✓
blood vessels
'
mguy
Gomoiedotoopdme →
pituitary glands
• Glucose is a reducing monosaccharide that serves as the principal
fuel of all the tissues.
• Diabetes mellitus the blood glucose levels are very high.
• Some patients with very high blood glucose levels may develop
metabolic acidosis and ketosis caused by the increased fat
metabolism, the alternate source for energy.
• Hyperglycaemia is also noted in gestational diabetes of pregnancy
and may be found in pancreatic disease, pituitary and adrenal
disorders.
• A decreased level of blood glucose, hypoglycaemia is often associ-
ated with starvation, hyperinsulinaemia and in those who are taking
high insulin dose for therapy and hypoadrenalism.
side effect
when it the
patient will
strep to anti
using
→
-• edm : an
-
eameer ,
tushy
Bilirubin too many protein →
problems with liver ,
rainy
pancreas
→ da hose
thingy
• Bilirubin is formed from the haem fragment of hae moglobin
released by aged or damaged red blood cells. Liver, spleen
and bone marrow are the sites of bilirubin production.
• Bilirubin formed in spleen and bone marrow is transported to
the liver. In the liver it is converted into bilirubin conjugates
and diglucuronides.
• Any liver disease affects the above systems, and hence
bilirubin accumulates in serum leading to jaundice.
Transaminases
• The two transaminases of diagnostic importance are serum
glutamic oxaloacetate transaminase (SGO) also called
aspartate amino transferase or AST, and serum glutamic
pyruvate transaminase (SGPT) also called alanine amino
transferase or ALT.
• While AST is found in every tissue of the body, including red
blood cells, and is particularly high in the cardiac muscle, ALT
is present at moderately high concentration in liver but is low in
cardiac, skeletal muscle and other tissues.
• Both AST and ALT measurements are useful in the diagnosis
and monitoring of patients with hepatocellular disease.
the most common
type of
primary three earner
r
Renal function
Implications of abnormal results
Abnormal results (lower-than-normal creatinine clearance) may indicate:
•. acute tubular necrosis;
•. bladder outlet obstruction;
•. congestive heart failure;
•. dehydration;
•. glomerulonephritis;
•. renal ischemia (blood deficiency);
•. renal outflow obstruction (usually must affect both kidneys to reduce the
creatinine clearance);
•. shock;
•. acute renal failure;
•. chronic renal failure;
•. end-stage renal disease. feddmay disease
Liver function tests
Liver function tests
• Alanine amino-transferase (ALT) --- a marker of hepatitis
• A spartate aminotransferase(AST)---a marker of liverdamage, as is
albumin.
• Direct bilirubin and total bilirubin are markers for infant jaundice, whilst
alkaline phosphatase (ALP) is often elevated when the bile duct is
blocked.
• Gamma- glutamyltransferase (GGT). Isolated elevation of GGT level
may be induced by alcohol and aromatic medications, usually with no
actual liver disease.
• In determining the pathology of liver disorders the pattern of change in
the various biomarkers indicates the nature of disease.
Heart disease and lipid disorder tests
Lipid disorders, high blood cholesterol and triglycerides, increase the
risk for atherosclerosis, and thus for heart disease, stroke and
hypertension. There are three main serum forms of cholesterol
which are measured:
•. total cholesterol;
•. high-density lipoprotein (HDL) cholesterol; and
•. low-density lipoprotein (LDL) cholesterol.
•Along with triglycerides and Apolipoproteins (Apo A-1, etc.),
cholesterols are usually measured as a panel of tests.
•The laboratory test for HDL or LDL measures how much cholesterol
is present in high-density or low-density lipoprotein fractions, not the
actual
Several genetic disorders lead to abnormal levels of
cholesterol and triglycerides:
•. Familial combined hyperlipidemia
•. Familial dysbetalipoproteinemia
•. Familial hypercholesterolemia
•. Familial hypertriglyceridemia.
Abnormal cholesterol and triglyceride levels are more often caused by:
• . being overweight or obese (metabolic syndrome);
• . medications, including birth control pills, oestrogen,
corticosteroids, diuretics, beta blockers, and
• antidepressants;
• . pre -existing diseases, for example diabetes, hypo-
• thyroidism, Cushing’s syndrome, polycystic ovary
• syndrome and kidney disease;
• . excessive alcohol consumption;
• . diets that are high in saturated fats (red meat, egg
• yolks and high-fat dairy products) and transfatty
• acids (found in commercial processed foods);
• . lack of exercise and sedentary lifestyle;
• . smoking (depresses HDL levels).
Markers of myocardial infarction
Troponin T --- developed, Troponin T being spe- cific to
the cytoskeletal filaments found in heart muscle cells.
Troponin I and T are now the main stay markers of
myocardial infarction:
. Blood creatine kinase (CK or CPK) levels: male, 38---
174 units/L; female, 96---140 units/L;
. MBCK level: normally less than 5% of total CK;
. Troponin I and Troponin T: normally undetectable very
high in MI, but slight to moderate elevation during any
damage episode to heart tissue such as
inflammation --- myocarditis.
KIT FOR DIAGNOSIS (ABOTT)
Pancreatic function
Amylase
• PLAP
• AFP
• hCG
References
• Gaw, A. et al. (2008) Clinical Biochemistry, 4th edn, Churchill
Livingstone.
• Hughes, J. and Jefferson, J.A. (2008) Clinical Chemistry Made Easy, 1st
edn, Churchill Livingstone.